Ramsay Health Care shares rebound 15% in June: Can they keep going?

Find out what the experts tip for the ASX healthcare shares next.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care Ltd (ASX: RHC) shares have climbed higher into the green on Thursday morning.

At the time of writing, the ASX healthcare shares are up around 1% and changing hands at $41.62 a piece.

Today's increase comes off the back of a 3.5% price hike yesterday.

The latest share price increase means Ramsay Health Care shares have now recovered around 15% from a dip in early June and are around 20% higher year to date. Over the past year, the shares have risen 17%.

Group of doctors celebrate by pumping fists in the air.

Image source: Getty Images

What happened to Ramsay Health Care shares?

Ramsay Health Care is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

The company faced several headwinds in 2025, including depressed earnings, market volatility, and ongoing cost pressures.

The ASX healthcare sector overall was under immense pressure throughout late 2025 and into early 2026, as macroeconomic pressures, rising inflation, higher cost of living, and regulatory uncertainty drove a sector-wide share price downturn.

Why are the ASX healthcare shares now rebounding?

There hasn't been any price-sensitive news out of Ramsay Health Care shares to explain the share price turnaround in June.

It's likely the result of an overall ASX healthcare sector recovery, as investors rotated back into heavily discounted healthcare names and sentiment improved following the company's latest earnings results.

The recovery has also been supported by a turnaround in the company's finances. Ramsay Health Care posted its first-half FY26 results in February, where it confirmed underlying EBIT had grown 7.3%, underlying NPAT was up 8.1%, and its Australian hospital revenue was 8.2% higher. The company's shares spiked by more than 10% on the day of the results.

The stronger half-year result seems to have helped investor sentiment shift from concerns about cost pressures and volatility towards a recovery story.

To me, it looks like investors are still snapping up the shares while they're trading for cheap.

Can Ramsay Health Care shares keep climbing higher? Here's what the experts think

Analysts and brokers are divided about the outlook for Ramsay Health Care shares over the next 12 months.

Market Index data shows brokers are split between a buy and a sell rating. The average $40.60 target price, however, implies a potential 3% downside at the time of writing.

On TradingView data, sentiment is also split. Out of 12 analysts, seven have a hold rating on the healthcare stock. Another four rate the shares as a buy or strong buy, and one has a strong sell stance.

The average $41.30 target price implies a downside of around 1% at the time of writing. But some expect the shares to jump 13% higher to $47.17, and others tip the stock to crash 20% back down to $32.90 a piece.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A small child carrying a brief case tries to reach an elevator button outside closed elevator doors.
Healthcare Shares

Up 1,636%, but can 4DMedical shares reclaim their record high?

Can the US growth story drive the ASX star back to records?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Healthcare Shares

Mesoblast shares: Q4 earnings top projections

Ryoncil® uptake has exceeded initial projections

Read more »

A woman leans forward with her hands shielding her eyes as if she is looking intently for something.
Healthcare Shares

Up 36%: Can CSL shares keep rebounding?

Find out what experts expect from CSL shares next.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Is CSL a fallen ASX giant to buy in July?

Confidence has been shaken, but I think the long-term opportunity remains attractive.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

This red-hot ASX healthcare share hit a speed bump. What next?

The tech company must convert innovation into profits to justify its lofty valuation.

Read more »

Two health workers taking a break.
Healthcare Shares

Top broker tips 37% upside for this exciting ASX healthcare stock

This healthcare stock is one to watch.

Read more »

A woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares are slipping again. Is the comeback already over?

The healthcare stock needs evidence of recovering demand before rallying further.

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them.
Healthcare Shares

ResMed's $490m MatrixCare sale: What it means

ResMed announces $490 million sale of MatrixCare and future shareholder returns.

Read more »